Board of Directors

Strong committed leadership focused on advancing the future of pain management

Dr. Douglas M Hansell

Board Member

Dr Hansell has experience in large company MedDevice, healthcare startups, biotech & venture capital. Prior to Baxter, Dr. Hansell led the medical strategy that helped Cheetah Medical grow from startup to acquisition by Baxter in 4 years. Prior to Cheetah, Dr. Hansell was Chief Medical Officer for GE Healthcare and Covidien (Medtronic). Prior to industry, Dr. Hansell was CMO of an IDN in Boston. Alongside industry, he has a 30+ year academic career at Massachusetts General Hospital and Harvard Medical School in Boston.

Dr. Alan Levy - Board Member, Medasense

Dr. Alan Levy

Board Member

He then established and led multiple medical device companies, including Heartstream, that developed the first small, lightweight and easy-to-use automated external defibrillator.

Dr. Levy has also served as a Senior Advisor at Frazier Healthcare Ventures. He currently serves on the boards of multiple private and public healthcare companies.

Dr. Levy holds a BSc in Chemistry from City College of New York and a PhD and Honorary DSc from Purdue University.

Josep Ll. Sanfeliu

Board MembeR

Previously Josep has worked in the pharmaceutical industry as Corporate Development Director at Almirall where he was involved with business development and in charge of M&A and corporate investments and also worked as General Manager leading operations in the segment of home-healthcare services at DomusVi. 

Alejandro Weinstein

Board Member

In addition to his role as Board Member at Medasense Biometrics Ltd., Mr. Weinstein holds director or investor roles in various ventures in the pharmaceutical and healthcare industries, including Olive Tree Ventures, Vanterra and Davidson & W. He is a board member of Health Hero, Atida, Medneo GmbH, Grupo Procaps and Gauzy Ltd.

Mr. Weinstein received a Business and Administration degree from the Universidad Catolica de Chile and is a certified public auditor and accountant. He also a graduate of the OPM program at Harvard Business School.

Henry Weinstein, Medasense Board Member

Henry Weinstein

Board Member

He has a proven track record of launching over 300 products in the pharmaceutical industry in Latin America and completing more than 20 licensing deals including biotech products and medical devices. He currently serves as a Board Member of Convexity Scientific, Via Surgical and Dog Parker. He previously served on the board of BMRC, a biotech research consortium in Chile.

Galit Zuckerman Stark - CEO, Medasense

Galit Zuckerman Stark

Founder, CEO and board member

Before founding Medasense she led algorithm teams at Applied Materials and worked at Nokia-Siemens and Nice Systems. Galit started her technology career at the elite Israeli Defense Forces “Haman Talpiot” program. She also served as a consultant for several start-up companies in the field of signal and image processing including BoneTone Communications which was successfully acquired by DSPG Inc in 2011.

Galit holds an MSc degree in Electrical Engineering (cum laude, Engineering Faculty Excellence Program) and a BSc in Computer Engineering (cum laude, Adi Lautman special program for outstanding students TAU) from Tel Aviv University, Israel.

Dr. Shmuel Cabilly, Medasense Board Observer

Dr. Shmuel Cabilly

Board Observer

Today there are already twenty drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more. Dr. Cabilly was also a co-founder and a chief scientist of Ethrog Biotechnology where he invented major technologies in the field of chemistry.

Robert Gavshon, Medasense Board Observer

Robert Gavshon

Board Observer

Mr. Gavshon was a significant shareholder in, and served as an Executive Director of private and listed companies which developed icon brands. He has gained broad business experience in Australasia, USA and Asia and has been involved in a number of successful equity ventures where he has also taken Board and advisory roles.

Mr. Gavshon is widely respected for the extensive community service he has given and occupied leading positions in the Australian not-for-profit sector. He holds commerce and law degrees from the University of Witwatersrand, South Africa.

Maite Malet - Medasense Board Observer

Maite Malet

Board Observer

Previously, she was incubating tech companies (healthtech, insurtech, wellness, etc.) at Antai Ventures, leading venture builder in Southern Europe. Maite started her professional career at Deloitte Corporate Finance, unit responsible for M&A and debt restructuring operations in Spain.

Currently doing a graduate program at Harvard University in Corporate Innovation and Sustainability, Maite holds a bachelor’s degree in International Business from Pompeu Fabra University (UPF) and the University of Florida (Warrington College of Business), and a master’s degree in Digital Marketing by ISDI.